Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 9/2013

01.09.2013 | Article

Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals

verfasst von: F. M. Buyle, S. Metz-Gercek, R. Mechtler, W. V. Kern, H. Robays, D. Vogelaers, M. J. Struelens, on behalf of members of the Antibiotic Strategy International (ABS) Quality Indicators Team

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 9/2013

Einloggen, um Zugang zu erhalten

Abstract

This study describes the development of structure indicators for hospital antimicrobial stewardship programmes and pilot validation across European hospitals. A multi-disciplinary panel from four European countries developed structure indicators in three steps: identification and listing of indicators, remote ranking of indicators using multi-criteria scoring, selection of indicators in a face-to-face consensus meeting. Additionally, the top-ten indicators were identified as a minimal set of key indicators. A survey was sent to the directors of antimicrobial stewardship programmes in European hospitals. The yes/no answers for the indicators were transformed into numbers in order to calculate the total scores. A list of 58 indicators was selected and categorised into the following topics: antimicrobial stewardship services (12 items), tools (16 items), human resources and mandate (6 items), health care personnel development (4 items), basic diagnostic capabilities (6 items), microbiological rapid tests (2 items), evaluation of microbiological drug resistance data (3 items), antibiotic consumption control (5 items) and drug use monitoring (4 items). The indicator scores, reported by 11 pilot hospitals from five European countries, ranged from 32 to 50 (maximum score = 58) and from 5 to 10 points (maximum score = 10) for, respectively, the complete and the top-ten list. An international panel selected 58 potential structure indicators, among which was a minimal set of ten key structure indicators, that could be useful for assessment of the comprehensiveness and resource-intensity of antimicrobial stewardship programmes. There was significant heterogeneity among participating centres with regard to their score for structural components of effective antimicrobial stewardship.
Literatur
1.
Zurück zum Zitat Council of the European Union (2002) Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). OJEU 45:13–16 Council of the European Union (2002) Council recommendation of 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC). OJEU 45:13–16
2.
Zurück zum Zitat Allerberger F, Gareis R, Jindrák V, Struelens MJ (2009) Antibiotic stewardship implementation in the EU: the way forward. Expert Rev Anti Infect Ther 7:1175–1183PubMedCrossRef Allerberger F, Gareis R, Jindrák V, Struelens MJ (2009) Antibiotic stewardship implementation in the EU: the way forward. Expert Rev Anti Infect Ther 7:1175–1183PubMedCrossRef
3.
Zurück zum Zitat Allerberger F, Lechner A, Wechsler-Fördös A, Gareis R; on behalf of ABS International (2008) Optimization of antibiotic use in hospitals—antimicrobial stewardship and the EU project ABS international. Chemotherapy 54:260–267PubMedCrossRef Allerberger F, Lechner A, Wechsler-Fördös A, Gareis R; on behalf of ABS International (2008) Optimization of antibiotic use in hospitals—antimicrobial stewardship and the EU project ABS international. Chemotherapy 54:260–267PubMedCrossRef
4.
Zurück zum Zitat Buyle FM, Metz-Gercek S, Mechtler R, Kern WV, Robays H, Vogelaers D, Struelens MJ; Antibiotic Strategy International—ABS Quality Indicators Team (2012) Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics. J Antimicrob Chemother 67:2043–2046PubMedCrossRef Buyle FM, Metz-Gercek S, Mechtler R, Kern WV, Robays H, Vogelaers D, Struelens MJ; Antibiotic Strategy International—ABS Quality Indicators Team (2012) Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics. J Antimicrob Chemother 67:2043–2046PubMedCrossRef
5.
6.
Zurück zum Zitat Lawrence M, Olesen F (1997) Indicators of quality in health care. Eur J Gen Pract 3:103–108CrossRef Lawrence M, Olesen F (1997) Indicators of quality in health care. Eur J Gen Pract 3:103–108CrossRef
7.
Zurück zum Zitat Hoven JL, Haaijer-Ruskamp FM, Vander Stichele RH; DURQUIM Scientific Committee (2005) Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004). Eur J Clin Pharmacol 60:831–834PubMedCrossRef Hoven JL, Haaijer-Ruskamp FM, Vander Stichele RH; DURQUIM Scientific Committee (2005) Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004). Eur J Clin Pharmacol 60:831–834PubMedCrossRef
8.
Zurück zum Zitat Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177PubMedCrossRef Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159–177PubMedCrossRef
9.
Zurück zum Zitat MacDougall C, Polk RE (2005) Antimicrobial stewardship programs in health care systems. Clin Microb Rev 18:638–656CrossRef MacDougall C, Polk RE (2005) Antimicrobial stewardship programs in health care systems. Clin Microb Rev 18:638–656CrossRef
10.
Zurück zum Zitat Sourdeau L, Struelens MJ, Peetermans WE, Costers M, Suetens C; Hospital Care Working Group of Belgian Antibiotic Policy Coordination Committee (BAPCOC) (2006) Implementation of antibiotic management teams in Belgian hospitals. Acta Clin Belg 61:58–63PubMed Sourdeau L, Struelens MJ, Peetermans WE, Costers M, Suetens C; Hospital Care Working Group of Belgian Antibiotic Policy Coordination Committee (BAPCOC) (2006) Implementation of antibiotic management teams in Belgian hospitals. Acta Clin Belg 61:58–63PubMed
11.
Zurück zum Zitat Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P (2005) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 19(4):CD003543 Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P (2005) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 19(4):CD003543
12.
Zurück zum Zitat Knox K, Lawson W, Holmes A (2005) Multidisciplinary antimicrobial management teams and the role of the pharmacist in management of infection. In: Gould IM, van der Meer JWM (eds) Antibiotic policies: theory and practice. Springer US, New York, pp 227–249CrossRef Knox K, Lawson W, Holmes A (2005) Multidisciplinary antimicrobial management teams and the role of the pharmacist in management of infection. In: Gould IM, van der Meer JWM (eds) Antibiotic policies: theory and practice. Springer US, New York, pp 227–249CrossRef
13.
Zurück zum Zitat Nathwani D (1999) How do you measure the impact of an antibiotic policy? J Hosp Infect 43:S265–S268PubMedCrossRef Nathwani D (1999) How do you measure the impact of an antibiotic policy? J Hosp Infect 43:S265–S268PubMedCrossRef
14.
Zurück zum Zitat Nathwani D, Gray K, Borland H (2002) Quality indicators for antibiotic control programmes. J Hosp Infect 50:165–169PubMedCrossRef Nathwani D, Gray K, Borland H (2002) Quality indicators for antibiotic control programmes. J Hosp Infect 50:165–169PubMedCrossRef
15.
Zurück zum Zitat Struelens MJ, Costers M; Belgian Antibiotic Policy Coordination Committee (BAPCOC)-Hospital Care Working Group (2008) Hospital antibiotic management in Belgium—results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr 120:284–288PubMedCrossRef Struelens MJ, Costers M; Belgian Antibiotic Policy Coordination Committee (BAPCOC)-Hospital Care Working Group (2008) Hospital antibiotic management in Belgium—results of the ABS maturity survey of the ABS International group. Wien Klin Wochenschr 120:284–288PubMedCrossRef
16.
Zurück zum Zitat Van Gastel E, Costers M, Peetermans WE, Struelens MJ; Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee (2010) Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother 65:576–580PubMedCrossRef Van Gastel E, Costers M, Peetermans WE, Struelens MJ; Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination Committee (2010) Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother 65:576–580PubMedCrossRef
17.
Zurück zum Zitat Schouten JA, Hulscher ME, Wollersheim H, Braspennning J, Kullberg BJ, van der Meer JW, Grol RP (2005) Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it? Clin Infect Dis 41:450–460PubMedCrossRef Schouten JA, Hulscher ME, Wollersheim H, Braspennning J, Kullberg BJ, van der Meer JW, Grol RP (2005) Quality of antibiotic use for lower respiratory tract infections at hospitals: (how) can we measure it? Clin Infect Dis 41:450–460PubMedCrossRef
18.
Zurück zum Zitat Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, Gould IM; ARPAC Steering Group (2009) Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother 64:853–860PubMedCrossRef Bruce J, MacKenzie FM, Cookson B, Mollison J, van der Meer JW, Krcmery V, Gould IM; ARPAC Steering Group (2009) Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother 64:853–860PubMedCrossRef
19.
Zurück zum Zitat Society for Healthcare Epidemiology of America; Infectious Diseases Society of America; Pediatric Infectious Diseases Society (2012) Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 33:322–327CrossRef Society for Healthcare Epidemiology of America; Infectious Diseases Society of America; Pediatric Infectious Diseases Society (2012) Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 33:322–327CrossRef
20.
Zurück zum Zitat Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, Eastaway A, Seaton R, Watson E, Gillies G; Scottish Antimicrobial Prescribing Group (2011) Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents 38:16–26PubMedCrossRef Nathwani D, Sneddon J, Malcolm W, Wiuff C, Patton A, Hurding S, Eastaway A, Seaton R, Watson E, Gillies G; Scottish Antimicrobial Prescribing Group (2011) Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents 38:16–26PubMedCrossRef
21.
Zurück zum Zitat Kern WV, Metz-Gercek S, Buyle F, Jindrak V, Lechner A, Mittermayer H, Seifert H, Wechsler-Fördös A, Wenisch C, Zupanc-Leijko T, Mechtler R, Struelens M (2009) Staphylococcus aureus bloodstream infection management indicators as quality indicators for hospital antibiotic stewardship: feasibility study by the ABS International Quality Indicators (ABS QI) team. Abstract of the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, May 2009. Abstract number P764 Kern WV, Metz-Gercek S, Buyle F, Jindrak V, Lechner A, Mittermayer H, Seifert H, Wechsler-Fördös A, Wenisch C, Zupanc-Leijko T, Mechtler R, Struelens M (2009) Staphylococcus aureus bloodstream infection management indicators as quality indicators for hospital antibiotic stewardship: feasibility study by the ABS International Quality Indicators (ABS QI) team. Abstract of the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland, May 2009. Abstract number P764
23.
Zurück zum Zitat McGowan JE Jr (2012) Antimicrobial stewardship—the state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol 33(4):331–337PubMedCrossRef McGowan JE Jr (2012) Antimicrobial stewardship—the state of the art in 2011: focus on outcome and methods. Infect Control Hosp Epidemiol 33(4):331–337PubMedCrossRef
24.
Zurück zum Zitat Malcolm W, Nathwani D, Davey P, Cromwell T, Patton A, Reilly J, Cairns S, Bennie M (2013) From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control 2(1):3PubMedCrossRef Malcolm W, Nathwani D, Davey P, Cromwell T, Patton A, Reilly J, Cairns S, Bennie M (2013) From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control 2(1):3PubMedCrossRef
26.
Zurück zum Zitat Morris AM, Brener S, Dresser L, Daneman N, Dellit TH, Avdic E, Bell CM (2012) Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 33:500–506PubMedCrossRef Morris AM, Brener S, Dresser L, Daneman N, Dellit TH, Avdic E, Bell CM (2012) Use of a structured panel process to define quality metrics for antimicrobial stewardship programs. Infect Control Hosp Epidemiol 33:500–506PubMedCrossRef
27.
Zurück zum Zitat Dumartin C, Rogues AM, Amadeo B, Pefau M, Venier AG, Parneix P, Maurain C (2011) Antibiotic stewardship programmes: legal framework and structure and process indicator in Southwestern French hospitals, 2005–2008. J Hosp Infect 77:123–128PubMedCrossRef Dumartin C, Rogues AM, Amadeo B, Pefau M, Venier AG, Parneix P, Maurain C (2011) Antibiotic stewardship programmes: legal framework and structure and process indicator in Southwestern French hospitals, 2005–2008. J Hosp Infect 77:123–128PubMedCrossRef
28.
Zurück zum Zitat Rello J, Lode H, Cornaglia G, Masterton R; VAP Care Bundle Contributors (2010) A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 36:773–780PubMedCrossRef Rello J, Lode H, Cornaglia G, Masterton R; VAP Care Bundle Contributors (2010) A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 36:773–780PubMedCrossRef
29.
Zurück zum Zitat Pope SD, Dellit TH, Owens RC, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America (2009) Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 30:97–98PubMedCrossRef Pope SD, Dellit TH, Owens RC, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America (2009) Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 30:97–98PubMedCrossRef
Metadaten
Titel
Development and validation of potential structure indicators for evaluating antimicrobial stewardship programmes in European hospitals
verfasst von
F. M. Buyle
S. Metz-Gercek
R. Mechtler
W. V. Kern
H. Robays
D. Vogelaers
M. J. Struelens
on behalf of members of the Antibiotic Strategy International (ABS) Quality Indicators Team
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 9/2013
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-013-1862-4

Weitere Artikel der Ausgabe 9/2013

European Journal of Clinical Microbiology & Infectious Diseases 9/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.